As noted in my last post, the selective advantage of heterozygosity for the sickle allele at the beta-globin locus has been known since Allison’s report in 1954 (Lancet). Nevertheless, a plausible and detailed mechanism to account for the protective effect of an...
There is probably no more canonical example of the relevance of evolutionary genetics to clinical medicine than sickle cell disease. The relevance of the sickle allele, in heterozygous form, at the beta-globin locus for resistance to falciparum malaria was published...
